Print


ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' requests relating to new instruments and monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
27181-27200 of 81374 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US00445A1007 ACELYRIN INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-07-07
US00445F1093 ACERAGEN INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-04-06
US0044681049 ACHIEVE LIFE SCIENCES INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0044682039 ACHIEVE LIFE SCIENCES INC; US COM NEW ESVUFR 2015 DELETED Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2023-02-06
US0044685008 ACHIEVE LIFE SCIENCES INC; US COM PAR $0.001 ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US00448Q2012 ACHILLION PHARMACEUTICALS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0044981019 ACI WORLDWIDE INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US00449L1026 ACHILLES THERAPEUTICS PLC; GB SPONSORED ADS EDSXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US00449R1095 ACCELLERON INDS AG; CH ADR EDSXDR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2022-10-10
US00461U1051 ACLARIS THERAPEUTICS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0047641065 ACME PACKET INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0048161048 ACME UTD CORP; US COM ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-05
US0048481073 ACORN ENERGY INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-09-09
US00484M1062 ACORDA THERAPEUTICS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US00484M6012 ACORDA THERAPEUTICS INC; US COM NEW ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-06-06
US00484M7002 ACORDA THERAPEUTICS INC; US COM PAR $0.001 ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2023-06-09
US00484N1046 ACOLA CORP; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0048541058 ACORN INTL INC; KY SPONSORED ADR EDSXFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0048542049 ACORN INTL INC; KY SPONSORED ADR NEW EDSXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US00486H1059 ADTRAN HLDGS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2022-07-13

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version

Print